EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
31/07/2026
Voltar para busca
Dado oficial do USPTO
DUNTAFY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
01/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
09/04/2019
Data de registro
29/09/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/09/2020
Última transação
01/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Wilmington, DE, US
Examinador
MARTIN, LIEF ANDREW
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
INCYTE HOLDINGS CORPORATION
MorphoSys AG
Representantes
Keith Toms, Esq. McCarter & English, LLP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disordersinfectious diseasescancerinflammatory diseasesAlzheimersepsisrestenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disordersinfectious diseasescancerinflammatory diseasesAlzheimersepsisrestenosis; antibodies sold as an ingredient of pharmaceuticals for the treatment of treatment of metabolic disordersinfectious diseasescancerinflammatory diseasesAlzheimersepsisrestenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disordersinfectious diseasescancerinflammatory diseasesAlzheimersepsisrestenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for the treatment of metabolic disordersinfectious diseasescancerinflammatory diseasesAlzheimersepsisrestenosis
Classe 42
research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design servicesscientific researchanalysistesting services in the fields of analytical chemistrybiochemistrymedicinal chemistrydrug developmentbiotechnologymicrobiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistrybiochemistrymedicinal chemistrydrug developmentbiotechnologymicrobiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disordersinfectious diseasescancerinflammatory diseasesAlzheimersepsisrestenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
31/07/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
31/07/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
31/07/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
31/07/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
31/07/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
29/09/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/06/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/06/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/06/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
17/06/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
17/06/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/05/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
24/04/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
29/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/07/2020
PUBO
PUBLISHED FOR OPPOSITION
14/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/06/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/06/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
08/06/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/06/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
08/06/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/05/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
28/05/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/12/2019
GNFR
FINAL REFUSAL E-MAILED
04/12/2019
CNFR
FINAL REFUSAL WRITTEN
04/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/12/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
19/06/2019
GNRT
NON-FINAL ACTION E-MAILED
19/06/2019
CNRT
NON-FINAL ACTION WRITTEN
19/06/2019
DOCK
ASSIGNED TO EXAMINER
19/06/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
07/05/2019
ALIE
ASSIGNED TO LIE
06/05/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
28/04/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/04/2019
NWAP
NEW APPLICATION ENTERED
12/04/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DUNTAFY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.